Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Cancer and Leukemia Group B 89901Robert J Mayer

Abstract

The addition of oxaliplatin to fluorouracil in patients with advanced colorectal cancer improves survival. This phase I/II study evaluated the addition of weekly oxaliplatin to preoperative continuous infusion fluorouracil (FU) and external-beam radiation therapy (RT) in patients with locally advanced rectal adenocarcinoma. Patients with clinical T3/T4 rectal adenocarcinoma and no evidence of metastases were treated with weekly oxaliplatin, continuous infusion FU 200 mg/m2 intravenously, and RT. A total of 6 weekly doses of oxaliplatin were planned. RT dose was 1.8 Gy/fraction to a total dose of 50.4 Gy. In the phase I portion, oxaliplatin was escalated from 30 to 60 mg/m2. Forty-four patients were entered onto the study, 18 on the phase I portion and 26 on the phase II portion. The maximum-tolerated dose (MTD) for oxaliplatin was determined to be 60 mg/m2. At the MTD, 12 patients experienced grade 3 or 4 diarrhea, two patients experienced grade 3 neutropenia, and one patient experienced grade 3 thrombocytopenia. Fifty-six percent of patients entered at the MTD completed all 6 weeks of oxaliplatin. Eight (25%) of 32 patients enrolled at the phase II dose experienced a pathologic complete response. In this multicenter study, the...Continue Reading

References

Jul 15, 1995·International Journal of Radiation Oncology, Biology, Physics·T A RichL D Roubein
Apr 30, 1995·International Journal of Radiation Oncology, Biology, Physics·G D WeinsteinD M Ota
Aug 30, 1994·International Journal of Radiation Oncology, Biology, Physics·E T ChenG Marks
Apr 2, 1993·International Journal of Radiation Oncology, Biology, Physics·A ChanR Khoo
May 1, 1996·Archives of Surgery·S J StrykerS M Poticha
Jan 15, 1997·International Journal of Radiation Oncology, Biology, Physics·B D MinskyJ Conti
Mar 10, 2001·International Journal of Radiation Oncology, Biology, Physics·A GrannB D Minsky
Jul 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G RosatiL Manzione
Sep 8, 2001·The New England Journal of Medicine·E KapiteijnUNKNOWN Dutch Colorectal Cancer Group
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre GérardGilles Freyer
Aug 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Claus RödelRolf Sauer
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M GoldbergSteven R Alberts
Jan 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J F BossetUNKNOWN EORTC Radiotherapy Group
Apr 7, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard L GundersonRichard M Goldberg
Jun 4, 2004·The New England Journal of Medicine·Thierry AndréUNKNOWN Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
Oct 22, 2004·The New England Journal of Medicine·Rolf SauerUNKNOWN German Rectal Cancer Study Group

❮ Previous
Next ❯

Citations

Nov 26, 2010·International Journal of Colorectal Disease·Francesco DionisiEnzo Banelli
Jul 29, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Jianhua JinJianzhong Deng
Dec 18, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Tara E SeeryJason A Zell
Jan 9, 2008·Current Treatment Options in Oncology·Bert H O'Neil, Joel E Tepper
Dec 16, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Asunción Hervás MorónEduardo Lobo Martínez
Aug 1, 2007·Clinics in Colon and Rectal Surgery·Smitha S KrishnamurthiTimothy J Kinsella
Jul 11, 2007·The Cancer Journal·Mathew Joseph, Al B Benson
Jul 11, 2007·The Cancer Journal·Shelileah Ramsey, Joel E Tepper
Jun 9, 2010·The Cancer Journal·Bruce D MinskyVincenzo Valentini
Jul 22, 2010·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S Gollins
Apr 5, 2007·Annals of Surgical Oncology·Christopher J GannonMiguel A Rodriguez-Bigas
Apr 24, 2010·The Oncologist·Michelle L MierzwaTheodore S Lawrence
Jan 1, 2009·Clinical and Experimental Gastroenterology·Somprakas BasuVijay K Shukla
Apr 12, 2008·Expert Review of Anticancer Therapy·Jeffrey J MeyerBrian G Czito
Jul 8, 2009·Expert Review of Molecular Diagnostics·Sergio HuertaDebabrata Saha
Jan 26, 2007·Expert Opinion on Biological Therapy·Nicolas Moosmann, Volker Heinemann
Mar 16, 2007·International Journal of Radiation Biology·Margret Rave-FränkElisabeth Weiss
Oct 7, 2011·Clinical Colorectal Cancer·Bruce D Minsky
Aug 4, 2011·Seminars in Oncology·Bruce D Minsky
Jun 15, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hagen KenneckeJohn Hay
Oct 16, 2010·International Journal of Radiation Oncology, Biology, Physics·Tom DipetrilloHoward Safran
Oct 5, 2010·Surgical Oncology Clinics of North America·Bruce D Minsky
Jun 12, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Y IshiiY Kitagawa
Nov 10, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·V S TheisS Lal
Nov 28, 2008·Clinical Colorectal Cancer·Peter J Hosein, Caio M Rocha-Lima
Feb 6, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·P SangheraA Hartley
Nov 17, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sigurd FolkvordAnne Hansen Ree
Jun 22, 2010·Cancer·Raymond C Wadlow, David P Ryan
Mar 13, 2010·American Journal of Surgery·Panagiotis TaflampasDimitris D A Tsiftsis
Oct 16, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Xin AnPei-Rong Ding

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Claus RodelRolf Sauer
The New England Journal of Medicine
Jean-François BossetEORTC Radiotherapy Group Trial 22921
The New England Journal of Medicine
Rolf SauerGerman Rectal Cancer Study Group
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jean-Pierre GérardLaurent Bedenne
© 2022 Meta ULC. All rights reserved